Free Trial

CRH (CRH) Financials

CRH logo
$84.79 -0.23 (-0.27%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$84.74 -0.04 (-0.05%)
As of 04/17/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for CRH

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
685 1,280 2,240 2,889 - 1,304 2,630 3,862 3,178 3,492
Consolidated Net Income / (Loss)
792 1,336 2,305 2,889 1,738 1,165 2,686 3,889 3,072 3,521
Net Income / (Loss) Continuing Operations
700 1,251 2,010 1,526 - 1,009 2,507 2,699 3,072 3,521
Total Pre-Tax Income
1,000 1,704 2,024 1,993 - 1,454 3,102 3,461 4,014 4,714
Total Operating Income
1,267 2,007 2,315 2,446 - 2,026 3,327 3,809 4,186 4,925
Total Gross Profit
7,240 8,651 8,863 9,058 9,273 8,565 9,827 10,815 11,963 12,701
Total Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Operating Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572
Total Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Operating Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871
Total Operating Expenses
5,973 6,643 6,548 6,612 - 6,539 6,500 7,006 7,777 7,776
Selling, General & Admin Expense
- - - - - - 6,538 7,056 7,486 7,852
Impairment Charge
- - - - - - 0.00 0.00 357 161
Other Special Charges / (Income)
- - - - - - -38 -50 -66 -237
Total Other Income / (Expense), net
-375 -359 -356 -453 - -589 -225 -348 -172 -211
Interest Expense
431 411 362 - - 438 315 344 376 612
Interest & Investment Income
8.69 8.42 14 - - 0.00 0.00 65 206 143
Other Income / (Expense), net
48 44 -8.41 -453 - -151 90 -69 -2.00 258
Income Tax Expense
300 453 14 467 - 445 650 762 925 1,085
Other Gains / (Losses), net
- - - - - - 55 0.00 -17 -108
Net Income / (Loss) Discontinued Operations
92 85 296 1,388 - 312 179 1,190 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 56 27 -106 29
Basic Earnings per Share
$0.89 $1.50 $2.72 - - $1.43 $3.35 $5.15 $4.36 $5.06
Weighted Average Basic Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 780.20M 758.30M 723.90M 683.30M
Diluted Earnings per Share
$0.89 $1.49 $2.71 - - $1.42 $3.32 $5.11 $4.33 $5.02
Weighted Average Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 786.80M 764.10M 729.20M 689.50M
Weighted Average Basic & Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 774.14M 752.14M 690.36M 676.48M
Cash Dividends to Common per Share
- - - - - - $1.21 $1.27 $1.33 $1.40

Quarterly Income Statements for CRH

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-28 1,199 1,306 701 116 1,297 1,376 703
Consolidated Net Income / (Loss)
-31 1,212 1,318 573 114 1,309 1,389 709
Net Income / (Loss) Continuing Operations
-31 1,212 1,318 573 114 1,309 1,389 709
Total Pre-Tax Income
-39 1,578 1,720 755 99 1,733 1,895 987
Total Operating Income
2.00 1,613 1,788 783 28 1,829 1,964 1,104
Total Gross Profit
1,619 3,630 3,763 2,951 1,807 3,675 4,059 3,160
Total Revenue
6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870
Operating Revenue
6,427 9,709 10,128 8,685 6,533 9,654 10,515 8,870
Total Cost of Revenue
4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710
Operating Cost of Revenue
4,808 6,079 6,365 5,734 4,726 5,979 6,456 5,710
Total Operating Expenses
1,617 2,017 1,975 2,168 1,779 1,846 2,095 2,056
Selling, General & Admin Expense
1,622 2,035 1,990 1,839 1,787 1,948 2,184 1,933
Other Special Charges / (Income)
-5.00 -18 -15 -28 -8.00 -102 -89 -38
Total Other Income / (Expense), net
-41 -35 -68 -28 71 -96 -69 -117
Interest Expense
81 73 131 91 133 155 164 160
Interest & Investment Income
40 36 62 68 43 36 33 31
Other Income / (Expense), net
0.00 2.00 1.00 -5.00 161 23 62 12
Income Tax Expense
-14 379 416 144 -19 430 531 143
Other Gains / (Losses), net
-6.00 13 14 -38 -4.00 6.00 25 -135
Net Income / (Loss) Attributable to Noncontrolling Interest
-3.00 13 12 -128 -2.00 12 13 6.00
Basic Earnings per Share
($0.05) $1.63 $1.81 $0.97 $0.16 $1.89 $1.99 $1.02
Weighted Average Basic Shares Outstanding
742.90M 734.70M 718.20M 723.90M 687.80M 685.50M 681.60M 683.30M
Diluted Earnings per Share
($0.05) $1.62 $1.80 $0.96 $0.16 $1.88 $1.97 $1.01
Weighted Average Diluted Shares Outstanding
742.90M 738.20M 722.10M 729.20M 693.40M 688.80M 685.50M 689.50M
Weighted Average Basic & Diluted Shares Outstanding
- - - 690.36M 686.68M 682.78M 679.34M 676.48M

Annual Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-4,181 -4,133 -5,388 -5,946 1,552 3,466 -1,938 153 454 -2,631
Net Cash From Operating Activities
1,057 -1,510 -2,392 -3,885 3,881 4,116 3,979 3,800 5,017 4,989
Net Cash From Continuing Operating Activities
1,057 -1,510 -2,392 -3,885 2,580 4,116 3,979 3,800 5,017 4,989
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 2,181 1,165 2,686 3,889 3,072 3,521
Consolidated Net Income / (Loss)
- - - - 2,181 1,165 2,686 3,889 3,072 3,521
Depreciation Expense
916 1,061 1,208 1,265 1,721 1,624 1,551 1,577 1,633 1,798
Non-Cash Adjustments To Reconcile Net Income
205 -2,511 -3,285 -4,539 -1,024 1,185 27 -1,242 547 -14
Changes in Operating Assets and Liabilities, net
-64 -60 -315 -611 -364 142 -285 -424 -235 -316
Net Cash From Investing Activities
-8,886 -1,054 -3,466 -5,400 217 -1,347 -2,513 -917 -2,391 -6,291
Net Cash From Continuing Investing Activities
-8,886 -1,054 -3,466 -5,400 -2,040 -1,347 -2,513 -917 -2,397 -6,291
Purchase of Property, Plant & Equipment
- - -1,254 -1,324 -1,374 -996 -1,554 -1,523 -1,817 -2,578
Acquisitions
- - -2,211 -4,076 -727 -351 -1,494 -3,253 -640 -4,900
Purchase of Investments
- - - - - - 0.00 -11 -1.00 -9.00
Sale of Property, Plant & Equipment
-958 -897 - - - - 387 115 104 272
Divestitures
-7,927 -157 - - - - 120 3,712 0.00 1,001
Sale and/or Maturity of Investments
- - - - 39 - 32 36 44 44
Other Investing Activities, net
- - - - 22 - -4.00 7.00 -87 -121
Net Cash From Financing Activities
3,648 -1,570 470 3,339 2,546 697 -3,107 -2,499 -2,380 -1,186
Net Cash From Continuing Financing Activities
3,648 -1,570 470 3,339 -2,485 697 -3,107 -2,499 -2,378 -1,186
Repayment of Debt
-41 0.00 -434 -291 -996 -4,943 -1,183 -364 -1,462 -1,859
Repurchase of Common Equity
- - -3.60 -921 -954 -249 -896 -1,178 -3,067 -1,482
Payment of Dividends
-416 -379 -573 -633 -663 -722 -946 -943 -975 -1,740
Issuance of Debt
4,105 -1,191 1,480 5,184 106 6,611 0.00 38 3,163 4,001
Other Financing Activities, net
- - - - 22 - -82 -52 -37 -106
Effect of Exchange Rate Changes
- - - - - - -297 -231 208 -143
Cash Interest Paid
328 364 381 394 - 432 340 329 418 599
Cash Income Taxes Paid
- - - - - - 642 1,043 959 960

Quarterly Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-1,286 -375 1,447 668 -3,081 637 -866 679
Net Cash From Operating Activities
-671 1,634 1,631 2,423 -712 1,485 1,486 2,730
Net Cash From Continuing Operating Activities
-671 1,634 1,631 2,423 -712 1,485 1,486 2,730
Net Income / (Loss) Continuing Operations
-31 1,212 1,318 573 114 1,309 1,389 709
Consolidated Net Income / (Loss)
-31 1,212 1,318 573 114 1,309 1,389 709
Depreciation Expense
384 401 402 446 397 424 467 510
Non-Cash Adjustments To Reconcile Net Income
36 44 16 451 -105 -80 -155 326
Changes in Operating Assets and Liabilities, net
-1,060 -23 -105 953 -1,118 -168 -215 1,185
Net Cash From Investing Activities
-492 -478 -759 -662 -2,096 -521 -1,788 -1,886
Net Cash From Continuing Investing Activities
-492 -478 -759 -668 -2,096 -521 -1,788 -1,886
Purchase of Property, Plant & Equipment
-332 -439 -404 -642 -506 -624 -505 -943
Acquisitions
-155 -43 -363 -79 -2,206 -316 -1,331 -1,047
Purchase of Investments
-2.00 9.00 -4.00 -4.00 -13 10 -18 12
Sale of Property, Plant & Equipment
6.00 36 22 40 739 357 84 -908
Divestitures
- - 5.00 -5.00 - - 27 919
Sale and/or Maturity of Investments
8.00 4.00 11 21 6.00 9.00 7.00 22
Other Investing Activities, net
-17 -45 -26 1.00 -116 -12 -52 59
Net Cash From Financing Activities
-191 -1,555 649 -1,283 -176 -339 -629 -42
Net Cash From Continuing Financing Activities
-191 -1,555 649 -1,281 -176 -339 -629 -42
Repayment of Debt
0.00 -849 -91 -522 -651 -1,040 -163 -5.00
Repurchase of Common Equity
-246 -713 -1,072 -1,036 -559 -348 -317 -258
Payment of Dividends
-13 -771 -12 -179 -767 -486 -249 -238
Issuance of Debt
71 784 1,832 476 1,818 1,552 82 549
Other Financing Activities, net
-3.00 -6.00 -8.00 -20 -17 -17 18 -90
Effect of Exchange Rate Changes
68 24 -74 190 -97 12 65 -123
Cash Interest Paid
54 147 43 174 45 171 156 227
Cash Income Taxes Paid
104 173 343 339 159 145 350 306

Annual Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Current Assets
9,882 11,737 17,395 17,258 14,977 14,044 14,833 16,885 14,083
Cash & Equivalents
2,576 2,541 9,191 9,918 7,721 5,783 5,936 6,341 3,720
Restricted Cash
- - - - - - - 0.00 39
Accounts Receivable
4,186 4,361 4,665 4,231 4,086 4,569 4,300 4,507 4,820
Inventories, net
3,092 3,261 3,505 3,080 3,117 3,611 4,194 4,291 4,755
Other Current Assets
- - - - - - 403 478 749
Other Current Nonoperating Assets
- - - - - - - 1,268 0.00
Plant, Property, & Equipment, net
13,350 15,729 18,046 19,574 19,317 19,502 17,768 17,841 21,452
Total Noncurrent Assets
10,005 10,533 11,336 10,780 10,650 11,124 12,718 12,743 15,078
Long-Term Investments
1,367 1,499 1,332 775 626 653 649 620 737
Goodwill
- - - - - - 9,199 9,158 11,061
Intangible Assets
8,165 8,666 9,656 9,475 9,373 9,848 1,088 1,041 1,211
Other Noncurrent Operating Assets
83 66 60 98 197 275 1,782 1,924 2,069
Total Liabilities & Shareholders' Equity
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613
Total Liabilities
18,043 20,008 27,825 27,977 24,596 23,756 22,279 25,848 27,763
Total Current Liabilities
6,690 7,516 14,006 13,411 7,465 7,581 8,041 10,013 10,296
Short-Term Debt
289 380 7,213 6,616 1,257 549 1,491 1,866 2,999
Accounts Payable
5,550 5,718 5,817 5,461 5,503 6,409 2,930 3,149 3,207
Accrued Expenses
- - - - - - 2,132 2,296 2,248
Other Current Liabilities
436 869 468 769 797 790 1,488 2,327 1,842
Other Current Nonoperating Liabilities
- - - - - - 0.00 375 0.00
Total Noncurrent Liabilities
11,353 12,492 13,819 14,566 17,131 16,175 14,238 15,835 17,467
Long-Term Debt
7,906 9,202 9,959 9,211 10,958 9,938 8,145 9,776 10,969
Noncurrent Deferred & Payable Income Tax Liabilities
2,112 2,001 2,530 2,627 2,613 2,734 2,885 2,738 3,105
Other Noncurrent Operating Liabilities
713 836 844 855 954 937 3,208 3,321 3,393
Commitments & Contingencies
- - - - - - 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 308 333 384
Total Equity & Noncontrolling Interests
15,193 17,990 18,951 19,634 20,347 20,914 22,732 21,288 22,466
Total Preferred & Common Equity
14,616 17,406 18,349 19,027 40,004 20,233 22,157 20,854 21,607
Preferred Stock
- - - - 7,493 - 1.00 1.00 1.00
Total Common Equity
14,616 17,406 18,349 19,027 12,162 20,232 22,156 20,853 21,606
Common Stock
299 344 352 335 333 309 745 750 712
Retained Earnings
6,809 9,493 11,705 11,350 11,565 19,770 22,495 22,918 24,036
Treasury Stock
-15 -18 -920 -360 -386 -195 -297 -2,199 -2,137
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -787 -616 -1,005
Noncontrolling Interest
576 584 602 607 692 681 575 434 859

Quarterly Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
45,107 46,142 47,631 46,333 48,105 51,221
Total Current Assets
14,230 15,074 16,315 13,709 15,113 14,840
Cash & Equivalents
4,650 4,275 5,722 3,308 3,066 2,978
Restricted Cash
- 0.00 0.00 - 869 102
Accounts Receivable
4,706 6,119 5,972 4,798 5,893 6,422
Inventories, net
4,458 4,276 4,191 4,619 4,514 4,644
Other Current Assets
416 404 430 748 704 694
Other Current Nonoperating Assets
0.00 0.00 0.00 236 67 0.00
Plant, Property, & Equipment, net
17,997 18,155 18,103 18,878 19,235 21,289
Total Noncurrent Assets
12,880 12,913 13,213 13,746 13,757 15,092
Long-Term Investments
655 672 665 609 484 929
Goodwill
9,308 9,338 9,545 10,125 10,251 10,906
Intangible Assets
1,094 1,061 1,074 1,093 1,086 1,105
Other Noncurrent Operating Assets
1,823 1,842 1,929 1,919 1,936 2,152
Total Liabilities & Shareholders' Equity
45,107 46,142 47,631 46,333 48,105 51,221
Total Liabilities
22,963 23,433 24,983 25,591 26,654 28,055
Total Current Liabilities
9,255 9,671 9,191 9,997 10,548 10,668
Short-Term Debt
2,251 2,185 1,860 2,992 3,218 3,218
Accounts Payable
2,627 3,553 2,954 2,730 3,363 2,963
Accrued Expenses
2,079 2,335 2,457 2,241 2,272 2,513
Other Current Liabilities
2,298 1,598 1,920 1,990 1,681 1,974
Other Current Nonoperating Liabilities
0.00 0.00 0.00 44 14 0.00
Total Noncurrent Liabilities
13,708 13,762 15,792 15,594 16,106 17,387
Long-Term Debt
7,583 7,563 9,535 9,680 9,900 10,672
Noncurrent Deferred & Payable Income Tax Liabilities
2,972 3,010 3,050 2,684 2,914 3,168
Other Noncurrent Operating Liabilities
3,153 3,189 3,207 3,230 3,292 3,547
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
307 313 320 326 335 361
Total Equity & Noncontrolling Interests
21,837 22,396 22,328 20,416 21,116 22,805
Total Preferred & Common Equity
21,255 21,821 21,767 20,015 20,726 21,875
Preferred Stock
1.00 1.00 1.00 1.00 1.00 1.00
Total Common Equity
21,254 21,820 21,766 20,014 20,725 21,874
Common Stock
722 693 725 631 651 683
Retained Earnings
21,692 22,892 23,936 22,346 23,030 23,831
Treasury Stock
-487 -1,140 -2,132 -2,166 -2,143 -2,141
Accumulated Other Comprehensive Income / (Loss)
-673 -625 -763 -797 -813 -499
Noncontrolling Interest
582 575 561 401 390 930

Annual Metrics and Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 12.12% -0.26% 5.43% 0.00% 0.00% 12.82% 12.04% 6.80% 1.78%
EBITDA Growth
0.00% 39.55% 12.91% -9.14% -45.15% 95.80% 41.98% 7.03% 9.40% 20.01%
EBIT Growth
0.00% 56.03% 12.43% -16.16% -100.00% 0.00% 82.24% 9.45% 11.87% 23.88%
NOPAT Growth
0.00% 66.12% 56.01% -18.51% -100.00% 0.00% 87.05% 12.95% 8.45% 17.70%
Net Income Growth
0.00% 68.67% 72.54% 25.33% -39.84% -32.97% 130.56% 44.79% -21.01% 14.62%
EPS Growth
0.00% 68.09% 81.60% 0.00% 0.00% 0.00% 133.80% 53.92% -15.26% 15.94%
Operating Cash Flow Growth
0.00% -242.79% -58.43% -62.44% 199.90% 6.06% -3.33% -4.50% 32.03% -0.56%
Free Cash Flow Firm Growth
0.00% 0.00% 97.57% -257.21% 63.29% 454.28% -7.67% 70.22% 22.77% -179.97%
Invested Capital Growth
0.00% 0.00% 14.08% 15.47% 2.23% -2.36% 2.98% -0.79% -2.61% 27.21%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.52%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.11%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.98%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.69%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.02%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.01%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.56%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.19%
Profitability Metrics
- - - - - - - - - -
Gross Margin
31.13% 33.17% 34.07% 33.03% 0.00% 33.08% 33.65% 33.05% 34.23% 35.71%
EBITDA Margin
9.59% 11.94% 13.51% 11.88% 0.00% 13.52% 17.01% 16.25% 16.64% 19.63%
Operating Margin
5.45% 7.70% 8.90% 8.92% 0.00% 7.83% 11.39% 11.64% 11.98% 13.85%
EBIT Margin
5.65% 7.87% 8.87% 7.27% 0.00% 7.24% 11.70% 11.43% 11.97% 14.57%
Profit (Net Income) Margin
3.41% 5.12% 8.86% 10.53% 0.00% 4.50% 9.20% 11.88% 8.79% 9.90%
Tax Burden Percent
79.24% 78.40% 113.89% 144.96% 0.00% 80.12% 86.59% 112.37% 76.53% 74.69%
Interest Burden Percent
76.03% 83.08% 87.76% 100.00% 0.00% 77.55% 90.78% 92.54% 95.94% 90.95%
Effective Tax Rate
30.00% 26.60% 0.71% 23.43% 0.00% 30.61% 20.95% 22.02% 23.04% 23.02%
Return on Invested Capital (ROIC)
0.00% 15.17% 11.06% 7.85% 0.00% 5.44% 10.15% 11.34% 12.51% 13.13%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 8.68% 11.22% 26.67% 0.00% 1.33% 11.21% 33.12% 8.14% 9.06%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.42% 2.84% 7.80% 0.00% 0.39% 2.87% 6.36% 1.25% 2.70%
Return on Equity (ROE)
0.00% 17.59% 13.89% 15.64% 9.01% 5.83% 13.02% 17.70% 13.76% 15.84%
Cash Return on Invested Capital (CROIC)
0.00% -184.83% -2.09% -6.52% -2.21% 7.83% 7.21% 12.14% 15.16% -10.81%
Operating Return on Assets (OROA)
0.00% 6.17% 6.48% 4.70% 0.00% 4.05% 7.63% 8.31% 9.02% 10.57%
Return on Assets (ROA)
0.00% 4.02% 6.47% 6.82% 0.00% 2.52% 5.99% 8.64% 6.62% 7.18%
Return on Common Equity (ROCE)
0.00% 16.92% 13.41% 15.14% 8.73% 4.55% 10.22% 17.07% 13.25% 15.12%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.14% 13.24% 15.74% 9.13% 2.91% 13.28% 17.55% 14.73% 16.30%
Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 1,873 0.00 1,406 2,630 2,970 3,221 3,791
NOPAT Margin
3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 9.00% 9.08% 9.22% 10.66%
Net Nonoperating Expense Percent (NNEP)
0.00% 6.49% -0.16% -18.82% -26.43% 4.11% -1.06% -21.78% 4.37% 4.08%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.18% 9.78% 10.41%
Cost of Revenue to Revenue
68.87% 66.83% 65.93% 67.06% 0.00% 66.92% 66.35% 66.95% 65.77% 64.30%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.39% 21.56% 21.42% 22.07%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.68% 25.48% 25.17% 24.11% 0.00% 25.26% 22.26% 21.41% 22.25% 21.86%
Earnings before Interest and Taxes (EBIT)
1,315 2,051 2,306 1,993 0.00 1,875 3,417 3,740 4,184 5,183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,231 3,113 3,515 3,258 1,787 3,499 4,968 5,317 5,817 6,981
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.09 1.65 2.68 2.03 1.30 2.46 2.91
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 2.29 3.29 11.67 3.96 2.43 4.81 6.73
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.73 0.00 1.26 1.41 0.88 1.46 1.77
Price to Earnings (P/E)
0.00 0.00 0.00 6.90 0.00 24.95 15.65 7.46 16.11 18.00
Dividend Yield
2.84% 2.38% 2.27% 3.41% 2.15% 2.23% 2.26% 0.00% 1.95% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 14.48% 0.00% 4.01% 6.39% 13.41% 6.21% 5.56%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.06 1.48 1.80 1.80 1.25 2.23 2.28
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.99 0.00 1.77 1.62 1.00 1.62 2.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 8.34 21.60 13.12 9.51 6.16 9.74 10.54
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 13.64 0.00 24.49 13.82 8.75 13.54 14.19
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 14.51 0.00 32.65 17.96 11.02 17.58 19.40
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 9.95 11.15 11.87 8.62 11.29 14.75
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 22.69 25.28 10.30 14.51 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.54 0.53 0.91 0.88 0.67 0.57 0.42 0.54 0.61
Long-Term Debt to Equity
0.00 0.52 0.51 0.53 0.54 0.60 0.54 0.35 0.45 0.48
Financial Leverage
0.00 0.28 0.25 0.29 0.34 0.29 0.26 0.19 0.15 0.30
Leverage Ratio
0.00 2.19 2.15 2.29 2.45 2.32 2.17 2.05 2.08 2.21
Compound Leverage Factor
0.00 1.82 1.88 2.29 0.00 1.80 1.97 1.89 1.99 2.01
Debt to Total Capital
0.00% 35.04% 34.75% 47.54% 46.72% 39.98% 36.19% 29.49% 35.00% 37.94%
Short-Term Debt to Total Capital
0.00% 1.24% 1.38% 19.97% 17.95% 3.71% 1.68% 4.56% 5.61% 8.15%
Long-Term Debt to Total Capital
0.00% 33.80% 33.37% 27.57% 28.77% 36.27% 34.51% 24.93% 29.39% 29.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 22.10% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.46% 2.12% 1.67% 1.65% 2.04% 2.08% 2.70% 2.31% 3.38%
Common Equity to Total Capital
0.00% 62.50% 63.13% 50.80% 51.63% 35.88% 61.73% 67.81% 62.69% 58.68%
Debt to EBITDA
0.00 2.63 2.73 5.27 9.64 3.87 2.39 1.81 2.00 2.00
Net Debt to EBITDA
0.00 1.36 1.56 2.04 3.65 1.48 1.08 0.57 0.80 1.36
Long-Term Debt to EBITDA
0.00 2.54 2.62 3.06 5.93 3.51 2.28 1.53 1.68 1.57
Debt to NOPAT
0.00 5.56 4.17 9.17 0.00 9.64 4.51 3.24 3.61 3.68
Net Debt to NOPAT
0.00 2.87 2.39 3.54 0.00 3.69 2.05 1.03 1.45 2.50
Long-Term Debt to NOPAT
0.00 5.37 4.00 5.32 0.00 8.75 4.30 2.74 3.03 2.89
Altman Z-Score
0.00 0.00 0.00 1.59 1.11 2.07 2.74 2.64 3.07 3.15
Noncontrolling Interest Sharing Ratio
0.00% 3.79% 3.50% 3.21% 3.13% 21.99% 21.49% 3.56% 3.70% 4.52%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.48 1.56 1.24 1.29 2.01 1.85 1.84 1.69 1.37
Quick Ratio
0.00 1.01 0.92 0.99 1.06 1.58 1.37 1.27 1.08 0.83
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -17,949 -435 -1,555 -571 2,023 1,868 3,179 3,903 -3,122
Operating Cash Flow to CapEx
110.32% -168.23% -190.71% -293.43% 282.46% 413.25% 340.96% 269.89% 292.88% 216.35%
Free Cash Flow to Firm to Interest Expense
0.00 -43.64 -1.20 0.00 0.00 4.62 5.93 9.24 10.38 -5.10
Operating Cash Flow to Interest Expense
2.45 -3.67 -6.61 0.00 0.00 9.40 12.63 11.05 13.34 8.15
Operating Cash Flow Less CapEx to Interest Expense
0.23 -5.85 -10.08 0.00 0.00 7.12 8.93 6.95 8.79 4.38
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.78 0.73 0.65 0.00 0.56 0.65 0.73 0.75 0.73
Accounts Receivable Turnover
0.00 6.23 6.09 6.08 0.00 6.23 6.75 7.38 7.94 7.63
Inventory Turnover
0.00 5.64 5.40 5.44 0.00 5.59 5.76 5.61 5.42 5.06
Fixed Asset Turnover
0.00 1.95 1.79 1.62 0.00 1.33 1.50 1.76 1.96 1.81
Accounts Payable Turnover
0.00 3.14 3.04 3.19 0.00 3.16 3.25 4.69 7.56 7.20
Days Sales Outstanding (DSO)
0.00 58.59 59.97 60.06 0.00 58.63 54.08 49.46 45.99 47.85
Days Inventory Outstanding (DIO)
0.00 64.76 67.62 67.15 0.00 65.29 63.36 65.02 67.37 72.18
Days Payable Outstanding (DPO)
0.00 116.25 119.93 114.46 0.00 115.51 112.18 77.80 48.26 50.72
Cash Conversion Cycle (CCC)
0.00 7.10 7.66 12.74 0.00 8.41 5.26 36.68 65.09 69.32
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 19,422 22,156 25,584 26,155 25,538 26,300 26,091 25,409 32,322
Invested Capital Turnover
0.00 2.69 1.25 1.15 0.00 1.00 1.13 1.25 1.36 1.23
Increase / (Decrease) in Invested Capital
0.00 19,422 2,734 3,428 571 -617 762 -209 -682 6,913
Enterprise Value (EV)
0.00 0.00 0.00 27,179 38,598 45,909 47,228 32,740 56,643 73,568
Market Capitalization
0.00 0.00 0.00 19,945 31,471 32,534 41,161 28,805 51,194 62,852
Book Value per Share
$0.00 $0.00 $20.75 $21.87 $22.56 $15.21 $25.44 $29.22 $27.72 $31.80
Tangible Book Value per Share
$0.00 $0.00 $10.42 $10.36 $11.33 $3.49 $13.06 $15.65 $14.16 $13.74
Total Capital
0.00 23,388 27,571 36,123 36,854 33,901 32,775 32,676 33,263 36,818
Total Debt
0.00 8,195 9,581 17,172 17,220 13,554 11,861 9,636 11,642 13,968
Total Long-Term Debt
0.00 7,906 9,202 9,959 10,604 12,297 11,312 8,145 9,776 10,969
Net Debt
0.00 4,228 5,501 6,632 6,520 5,190 5,386 3,051 4,681 9,472
Capital Expenditures (CapEx)
958 897 1,254 1,324 1,374 996 1,167 1,408 1,713 2,306
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 882 2,019 1,394 538 1,031 1,190 2,347 2,397 3,027
Debt-free Net Working Capital (DFNWC)
0.00 3,482 4,601 10,602 10,463 8,769 7,012 8,283 8,738 6,786
Net Working Capital (NWC)
0.00 3,193 4,221 3,389 3,847 7,512 6,463 6,792 6,872 3,787
Net Nonoperating Expense (NNE)
95 137 -6.88 -1,016 -1,738 241 -56 -919 149 270
Net Nonoperating Obligations (NNO)
0.00 4,229 4,166 6,633 6,521 5,191 5,386 3,051 3,788 9,472
Total Depreciation and Amortization (D&A)
916 1,061 1,208 1,265 1,787 1,624 1,551 1,577 1,633 1,798
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 3.38% 7.76% 5.08% 0.00% 3.98% 4.07% 7.17% 6.86% 8.51%
Debt-free Net Working Capital to Revenue
0.00% 13.35% 17.69% 38.66% 0.00% 33.87% 24.01% 25.31% 25.00% 19.08%
Net Working Capital to Revenue
0.00% 12.24% 16.23% 12.36% 0.00% 29.02% 22.13% 20.76% 19.66% 10.65%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.27 $3.02 $2.41 $142.90 $0.00 $5.07 $4.36 $5.06
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 723.90M 683.30M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.25 $3.01 $2.39 $141.80 $0.00 $5.03 $4.33 $5.02
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 729.20M 689.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 690.36M 676.48M
Normalized Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 1,873 0.00 1,406 2,600 2,931 3,445 3,733
Normalized NOPAT Margin
3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 8.90% 8.96% 9.86% 10.49%
Pre Tax Income Margin
4.30% 6.54% 7.78% 7.27% 0.00% 5.62% 10.62% 10.58% 11.49% 13.25%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
3.05 4.99 6.38 0.00 0.00 4.28 10.85 10.87 11.13 8.47
NOPAT to Interest Expense
2.06 3.58 6.36 0.00 0.00 3.21 8.35 8.63 8.57 6.20
EBIT Less CapEx to Interest Expense
0.83 2.81 2.91 0.00 0.00 2.01 7.14 6.78 6.57 4.70
NOPAT Less CapEx to Interest Expense
-0.17 1.40 2.89 0.00 0.00 0.94 4.64 4.54 4.01 2.43
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
52.54% 28.35% 24.86% 21.91% 38.15% 61.97% 35.22% 24.25% 31.74% 49.42%
Augmented Payout Ratio
52.54% 28.35% 25.01% 53.79% 93.04% 83.35% 68.58% 54.54% 131.58% 91.51%

Quarterly Metrics and Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 1.65% -0.57% 3.82% 2.13%
EBITDA Growth
0.00% 0.00% 0.00% 0.00% 51.81% 12.90% 13.78% 32.84%
EBIT Growth
0.00% 0.00% 0.00% 0.00% 9,350.00% 14.67% 13.25% 43.44%
NOPAT Growth
0.00% 0.00% 0.00% 0.00% 2,283.84% 12.21% 4.29% 48.98%
Net Income Growth
0.00% 0.00% 0.00% 0.00% 467.74% 8.00% 5.39% 23.73%
EPS Growth
0.00% 0.00% 0.00% 0.00% 420.00% 16.05% 9.44% 5.21%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -6.11% -9.12% -8.89% 12.67%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 9.87% 9.40% 19.49% 27.21%
Revenue Q/Q Growth
0.00% 51.07% 4.32% -14.25% 0.00% 47.77% 8.92% -15.64%
EBITDA Q/Q Growth
0.00% 422.28% 8.68% -44.14% 0.00% 288.40% 9.53% -34.78%
EBIT Q/Q Growth
0.00% 80,650.00% 10.77% -56.51% 0.00% 879.89% 9.40% -44.92%
NOPAT Q/Q Growth
0.00% 87,442.41% 10.60% -53.25% 0.00% 4,020.55% 2.80% -33.22%
Net Income Q/Q Growth
0.00% 4,009.68% 8.75% -56.53% 0.00% 1,048.25% 6.11% -48.96%
EPS Q/Q Growth
0.00% 3,340.00% 11.11% -46.67% 0.00% 1,075.00% 4.79% -48.73%
Operating Cash Flow Q/Q Growth
0.00% 343.52% -0.18% 48.56% 0.00% 308.57% 0.07% 83.71%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 53.37% -228.21% -50.07%
Invested Capital Q/Q Growth
0.00% 3.14% 0.53% -8.12% 0.00% 2.70% 9.80% -2.19%
Profitability Metrics
- - - - - - - -
Gross Margin
25.19% 37.39% 37.15% 33.98% 27.66% 38.07% 38.60% 35.63%
EBITDA Margin
6.01% 20.76% 21.63% 14.09% 8.97% 23.58% 23.71% 18.33%
Operating Margin
0.03% 16.61% 17.65% 9.02% 0.43% 18.95% 18.68% 12.45%
EBIT Margin
0.03% 16.63% 17.66% 8.96% 2.89% 19.18% 19.27% 12.58%
Profit (Net Income) Margin
-0.48% 12.48% 13.01% 6.60% 1.75% 13.56% 13.21% 7.99%
Tax Burden Percent
79.49% 76.81% 76.63% 75.89% 115.15% 75.53% 73.30% 71.83%
Interest Burden Percent
-1,950.00% 97.71% 96.14% 97.04% 52.38% 93.57% 93.53% 88.44%
Effective Tax Rate
0.00% 24.02% 24.19% 19.07% -19.19% 24.81% 28.02% 14.49%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 10.04% 0.64% 17.31% 15.67% 13.12%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 8.43% 1.87% 16.32% 15.34% 9.57%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 1.48% 0.57% 4.97% 4.99% 2.85%
Return on Equity (ROE)
0.00% 0.00% 0.00% 11.51% 1.21% 22.28% 20.66% 15.97%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 15.36% 0.00% 0.00% 0.00% -10.81%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 6.75% 2.22% 14.25% 13.79% 9.13%
Return on Assets (ROA)
0.00% 0.00% 0.00% 4.97% 1.34% 10.07% 9.46% 5.80%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 11.09% 1.17% 21.47% 19.68% 15.25%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 16.07% 15.99% 15.47% 0.00%
Net Operating Profit after Tax (NOPAT)
1.40 1,226 1,356 634 33 1,375 1,414 944
NOPAT Margin
0.02% 12.62% 13.38% 7.30% 0.51% 14.24% 13.44% 10.64%
Net Nonoperating Expense Percent (NNEP)
0.72% 0.28% 0.75% 1.60% -1.23% 0.98% 0.33% 3.55%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.92% - - - 2.59%
Cost of Revenue to Revenue
74.81% 62.61% 62.85% 66.02% 72.34% 61.93% 61.40% 64.37%
SG&A Expenses to Revenue
25.24% 20.96% 19.65% 21.17% 27.35% 20.18% 20.77% 21.79%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.16% 20.77% 19.50% 24.96% 27.23% 19.12% 19.92% 23.18%
Earnings before Interest and Taxes (EBIT)
2.00 1,615 1,789 778 189 1,852 2,026 1,116
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
386 2,016 2,191 1,224 586 2,276 2,493 1,626
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
1.70 1.83 1.83 2.46 2.98 2.48 2.89 2.91
Price to Tangible Book Value (P/TBV)
3.33 3.49 3.57 4.81 6.77 5.48 6.42 6.73
Price to Revenue (P/Rev)
0.00 0.00 0.00 1.46 1.70 1.47 1.79 1.77
Price to Earnings (P/E)
0.00 0.00 0.00 16.11 17.93 15.05 18.14 18.00
Dividend Yield
0.00% 0.00% 0.00% 1.95% 1.95% 2.71% 2.56% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 6.21% 5.58% 6.64% 5.51% 5.56%
Enterprise Value to Invested Capital (EV/IC)
1.56 1.66 1.65 2.23 2.36 2.02 2.25 2.28
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.62 1.97 1.74 2.11 2.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 9.74 11.47 9.70 11.32 10.54
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 13.54 15.79 13.22 15.38 14.19
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 17.58 21.06 17.76 21.35 19.40
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 11.29 13.87 12.62 15.91 14.75
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.44 0.43 0.50 0.54 0.61 0.61 0.60 0.61
Long-Term Debt to Equity
0.34 0.33 0.42 0.45 0.47 0.46 0.46 0.48
Financial Leverage
0.20 0.21 0.22 0.18 0.31 0.30 0.33 0.30
Leverage Ratio
2.04 2.03 2.10 2.08 2.13 2.13 2.16 2.21
Compound Leverage Factor
-39.72 1.99 2.02 2.02 1.12 2.00 2.02 1.95
Debt to Total Capital
30.75% 30.03% 33.47% 35.00% 37.92% 37.95% 37.48% 37.94%
Short-Term Debt to Total Capital
7.04% 6.73% 5.46% 5.61% 8.95% 9.31% 8.68% 8.15%
Long-Term Debt to Total Capital
23.71% 23.30% 28.01% 29.39% 28.97% 28.64% 28.80% 29.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.78% 2.74% 2.59% 2.31% 2.18% 2.10% 3.48% 3.38%
Common Equity to Total Capital
66.46% 67.23% 63.94% 62.69% 59.90% 59.95% 59.03% 58.68%
Debt to EBITDA
0.00 0.00 0.00 2.00 2.11 2.09 2.11 2.00
Net Debt to EBITDA
0.00 0.00 0.00 0.80 1.46 1.39 1.50 1.36
Long-Term Debt to EBITDA
0.00 0.00 0.00 1.68 1.61 1.58 1.62 1.57
Debt to NOPAT
0.00 0.00 0.00 3.61 3.86 3.82 3.98 3.68
Net Debt to NOPAT
0.00 0.00 0.00 1.45 2.67 2.54 2.83 2.50
Long-Term Debt to NOPAT
0.00 0.00 0.00 3.03 2.95 2.89 3.06 2.89
Altman Z-Score
0.00 0.00 0.00 2.83 2.94 2.80 2.92 2.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 3.70% 3.77% 3.66% 4.75% 4.52%
Liquidity Ratios
- - - - - - - -
Current Ratio
1.54 1.56 1.78 1.69 1.37 1.43 1.39 1.37
Quick Ratio
1.01 1.07 1.27 1.08 0.81 0.85 0.88 0.83
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 0.00 -2,599 -1,212 -3,977 -5,969
Operating Cash Flow to CapEx
-205.83% 405.46% 426.96% 402.49% 0.00% 556.18% 352.97% 147.49%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -19.54 -7.82 -24.25 -37.31
Operating Cash Flow to Interest Expense
-8.28 22.38 12.45 26.63 -5.35 9.58 9.06 17.06
Operating Cash Flow Less CapEx to Interest Expense
-12.31 16.86 9.53 20.01 -3.60 7.86 6.49 5.49
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.75 0.77 0.74 0.72 0.73
Accounts Receivable Turnover
0.00 0.00 0.00 7.94 7.38 5.83 5.71 7.63
Inventory Turnover
0.00 0.00 0.00 5.42 5.05 5.19 5.18 5.06
Fixed Asset Turnover
0.00 0.00 0.00 1.96 1.90 1.87 1.80 1.81
Accounts Payable Turnover
0.00 0.00 0.00 7.56 8.55 6.59 7.74 7.20
Days Sales Outstanding (DSO)
0.00 0.00 0.00 45.99 49.48 62.63 63.92 47.85
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 67.37 72.33 70.35 70.43 72.18
Days Payable Outstanding (DPO)
0.00 0.00 0.00 48.26 42.68 55.35 47.17 50.72
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 65.09 79.12 77.63 87.18 69.32
Capital & Investment Metrics
- - - - - - - -
Invested Capital
26,673 27,510 27,656 25,409 29,305 30,097 33,047 32,322
Invested Capital Turnover
0.00 0.00 0.00 1.38 1.25 1.22 1.17 1.23
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 0.00 2,632 2,587 5,391 6,913
Enterprise Value (EV)
41,537 45,573 45,711 56,643 69,033 60,912 74,494 73,568
Market Capitalization
36,118 39,883 39,821 51,194 59,550 51,487 63,321 62,852
Book Value per Share
$28.26 $29.01 $28.94 $27.72 $29.10 $30.18 $32.04 $31.80
Tangible Book Value per Share
$14.43 $15.18 $14.82 $14.16 $12.79 $13.67 $14.45 $13.74
Total Capital
31,978 32,457 34,043 33,263 33,414 34,569 37,056 36,818
Total Debt
9,834 9,748 11,395 11,642 12,672 13,118 13,890 13,968
Total Long-Term Debt
7,583 7,563 9,535 9,776 9,680 9,900 10,672 10,969
Net Debt
4,529 4,801 5,008 4,681 8,755 8,699 9,881 9,472
Capital Expenditures (CapEx)
326 403 382 602 -233 267 421 1,851
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,576 3,313 3,262 2,397 3,396 3,848 4,310 3,027
Debt-free Net Working Capital (DFNWC)
7,226 7,588 8,984 8,738 6,704 7,783 7,390 6,786
Net Working Capital (NWC)
4,975 5,403 7,124 6,872 3,712 4,565 4,172 3,787
Net Nonoperating Expense (NNE)
32 14 38 61 -81 66 25 235
Net Nonoperating Obligations (NNO)
4,529 4,801 5,008 3,788 8,563 8,646 9,881 9,472
Total Depreciation and Amortization (D&A)
384 401 402 446 397 424 467 510
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 6.86% 9.69% 10.99% 12.18% 8.51%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 25.00% 19.12% 22.24% 20.88% 19.08%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 19.66% 10.59% 13.04% 11.79% 10.65%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.97 $0.16 $1.89 $1.99 $1.02
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 723.90M 687.80M 685.50M 681.60M 683.30M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.96 $0.16 $1.88 $1.97 $1.01
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 729.20M 693.40M 688.80M 685.50M 689.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 690.36M 686.68M 682.78M 679.34M 676.48M
Normalized Net Operating Profit after Tax (NOPAT)
-2.10 1,212 1,344 611 14 1,298 1,350 912
Normalized NOPAT Margin
-0.03% 12.48% 13.27% 7.04% 0.21% 13.45% 12.84% 10.28%
Pre Tax Income Margin
-0.61% 16.25% 16.98% 8.69% 1.52% 17.95% 18.02% 11.13%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.02 22.12 13.66 8.55 1.42 11.95 12.35 6.98
NOPAT to Interest Expense
0.02 16.79 10.35 6.96 0.25 8.87 8.62 5.90
EBIT Less CapEx to Interest Expense
-4.00 16.60 10.74 1.93 3.17 10.23 9.79 -4.59
NOPAT Less CapEx to Interest Expense
-4.01 11.27 7.43 0.35 2.00 7.15 6.05 -5.67
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 31.74% 53.81% 43.63% 49.72% 49.42%
Augmented Payout Ratio
0.00% 0.00% 0.00% 131.58% 158.87% 134.61% 116.48% 91.51%

Frequently Asked Questions About CRH's Financials

When does CRH's fiscal year end?

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023.

What is CRH's operating income?
CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:
  • Total Gross Profit: $12.70 billion
  • Total Operating Expenses: $7.78 billion
How has CRH revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.



This page (NYSE:CRH) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners